MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$4,480K
(66.27%↑ Y/Y)
Income (loss) from
discontinued operations
$9,318K
Loss from continuing
operations
-$13,798K
Loss before income
taxes from continuing...
-$13,798K
(-3.88%↓ Y/Y)
US
$27,634K
(-50.99%↓ Y/Y)
GB
$6,685K
(21.35%↑ Y/Y)
Operating loss
-$8,274K
(41.23%↑ Y/Y)
Total other income
(expense)
-$5,524K
(-793.10%↓ Y/Y)
Revenues
$34,319K
(-44.56%↓ Y/Y)
Total costs and
expenses
$42,593K
(-43.94%↓ Y/Y)
Interest expense, net
-$2,533K
(-38.42%↓ Y/Y)
Foreign currency (gain)
loss
-$1,706K
(-164.94%↓ Y/Y)
Loss on investment
-$1,285K
Partner share and other
third-party costs
$14,597K
(-50.43%↓ Y/Y)
General and
administrative expense
$8,281K
(-39.90%↓ Y/Y)
Sales and marketing
expense
$6,761K
(-46.99%↓ Y/Y)
Research and development
expense
$6,430K
(-45.07%↓ Y/Y)
Depreciation and
amortization expense
$3,943K
(-37.32%↓ Y/Y)
Delivery costs
$2,581K
(-64.59%↓ Y/Y)
Back
Back
Income Statement
Cardlytics, Inc. (CDLX)
Cardlytics, Inc. (CDLX)
source: myfinsight.com